All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
Makers of COVID-19 vaccines are now destroying long-term safety studies by unblinding their trials and giving the control groups the active vaccine, claiming it is “unethical” to withhold an effective vaccine.
In so doing, they make it virtually impossible to assess any long-term safety and effectiveness, and the true benefit versus cost.
It’s ironic, because vaccine mandates are being justified on the premise that the benefit to the community is more important than an individual’s risk of harm. Yet vaccine manufacturers are saying that participants in the control groups are harmed by not getting the vaccine, and saving the individual is more important than securing the data needed to make public health decisions.
Getting the active vaccine comes with risk, not merely benefit. This is particularly true for the novel mRNA technology used in COVID-19 vaccines.
As of April 1, 2021, VAERS had received 56,869 adverse events following COVID-19 vaccination, including 7,971 serious injuries and 2,342 deaths. Of those deaths, 28% occurred within 48 hours of vaccination. The youngest person to die was 18 years old.
While reports of side effects from COVID-19 gene therapies, including life-threatening effects and deaths, continue to climb at breakneck speed,1 a one-sided narrative of safety and effectiveness permeates mainstream media and medical news.
These “vaccines” are so safe and so effective, according to this narrative, that keeping control groups intact for long-term study and comparison of outcomes is now being derided as “unethical,” despite the fact that there is absolutely no non-fraudulent data to support their perverse assertions. Truly, what we’re watching is the active destruction of basic medical science in a surreal dystopian nightmare.
Vaccine Makers to Ditch Control Groups
Consider this report in JAMA by Rita Rubin, senior writer for JAMA medical news and perspectives, for example.2 According to Rubin, the launch of “two highly efficacious” COVID-19 vaccines has “spurred debate about the ethics, let alone the feasibility, of continuing or launching blinded, placebo-controlled trials …”
Rubin recounts how Moderna representatives told a Food and Drug Administration advisory panel that rather than letting thousands of vaccine doses to go to waste,